Close Menu

Over at the Daily Transcript, Alex Palazzo has a post considering the business models in publishing and what it would take for open access to be the norm. He refers to an interview with Emily Marcus, editor of Cell, in his quest to find out just how viable open access could be. It's a thoughtful piece, and worth a look as the open access debate continues.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.